BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Pacific Standard Time BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0700 TZOFFSETTO:-0800 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0800 TZOFFSETTO:-0700 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20260508T064557Z DESCRIPTION:The Enhanced Liver Fibrosis (ELF) Test in Real-World Practice: From Laboratory Excellence to Clinical Action \nPresented by Siemens Healt hineers \nTuesday\, July 28 11:30 a.m. - 12:30 p.m. PDT (Anaheim\, Califor nia time)\nADLM 2026 Exhibit Hall Theater #1\nThis informative session exa mines the role of the Enhanced Liver Fibrosis (ELF®) Test in real‑world practice through a multidisciplinary lens. Each speaker will anchor their discussion on the importance of early risk assessment for disease progres sion in patients with MASH and how non-invasive tests can support earlier risk assessment and clinical action.\nPresenters: \nAmreen M. Dinani\, MD\ , MSc\, FRCPC\, ABOM\nAssociate Professor of Medicine\nDuke University Sch ool of Medicine\, USA\nNikola A. Baumann\, PhD\, DABCC \nVice Chair of Qua lity\, Department of Laboratory Medicine\, and Pathology\nDirector of Cent ral Clinical Laboratory and CLIA Lab Director\nMayo Clinic Laboratories\, USA\n\nModerator:\nLeontine Narcisse-Ogera\, MD\, PhD\nSVP\, Head of Medic al and Scientific Strategy\, Medical Communications\, eNova\nevents.siemen s-healthineers.com/adlm \nL unch will be provided for attendees.\n DTEND;TZID="Pacific Standard Time":20260728T123000 DTSTAMP:20260501T181549Z DTSTART;TZID="Pacific Standard Time":20260728T113000 LAST-MODIFIED:20260508T064557Z LOCATION:Siemens Healthineers presenting at ADLM 2026 Exhibit Hall Theater #1 PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:Liver Disease Workshop: The Enhanced Liver Fibrosis (ELF) Test in Real-World Practice: From Laboratory Excellence to Clinical Action TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E0080000000020E3C97974D9DC01000000000000000 0100000004FD5C0CC911C3E4DA7CAB0A7C9D54F2C X-ALT-DESC;FMTTYPE=text/html:\n\n\n

The Enhanced Liver Fibrosis (ELF) Test in Real-World Practice: Fro m Laboratory Excellence to Clinical Action

Presented by Siemens Healthi neers

Tuesday\, J uly 28 11:30 a.m. - 12:30 p.m. PDT (Anaheim\, California time)< /span>

ADLM 2026 Exh ibit Hall Theater #1

This informative session examines the role of the Enhan ced Liver Fibrosis (ELF®) Test in real‑world practice through a multidi sciplinary lens. Each speaker will anchor their discussion on the importan ce of early risk assessment for disease progression in patients with MASH and how non-invasive tests can support earlier risk assessment and clinica l action.

Presenters: \;
Amreen M. Dinani\, MD\, MSc\, FRCPC\, ABOM
Associate Professor of Medic ine
Duke University School of Medicine\, USA

Nikola A. Baumann\, PhD\, DABCC \;
Vice Chair of Quality\, Department of Laboratory Medicine\, and Pathology
Director of Central Clinical Laboratory and CLIA Lab Dire ctor
Mayo Clinic Laboratories\, USA

Moderator:
Leontine Narcisse-Ogera\, MD\, PhD< /span>
SVP\, Head of Medical and Scientific Strategy\, Medical Communications\, eNova

events.sieme ns-healthineers.com/adlm

Lunch will be provided for attendees.

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-AUTOFILLLOCATION:FALSE X-MS-OLK-CONFTYPE:0 END:VEVENT END:VCALENDAR